000 01618 a2200445 4500
005 20250514032000.0
264 0 _c20020522
008 200205s 0 0 eng d
022 _a0027-8874
024 7 _a10.1093/jnci/94.9.662
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLove, Richard R
245 0 0 _aMastectomy and oophorectomy by menstrual cycle phase in women with operable breast cancer.
_h[electronic resource]
260 _bJournal of the National Cancer Institute
_cMay 2002
300 _a662-9 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdult
650 0 4 _aAntineoplastic Agents, Hormonal
_xadministration & dosage
650 0 4 _aBreast Neoplasms
_xphysiopathology
650 0 4 _aChemotherapy, Adjuvant
650 0 4 _aDisease-Free Survival
650 0 4 _aFemale
650 0 4 _aFollicular Phase
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aLuteal Phase
650 0 4 _aMastectomy
650 0 4 _aMiddle Aged
650 0 4 _aOvariectomy
650 0 4 _aSurvival Analysis
650 0 4 _aTamoxifen
_xadministration & dosage
700 1 _aDuc, Nguyen Ba
700 1 _aDinh, Nguyen Van
700 1 _aShen, Tian-Zhen
700 1 _aHavighurst, Thomas C
700 1 _aAllred, D Craig
700 1 _aDeMets, David L
773 0 _tJournal of the National Cancer Institute
_gvol. 94
_gno. 9
_gp. 662-9
856 4 0 _uhttps://doi.org/10.1093/jnci/94.9.662
_zAvailable from publisher's website
999 _c11883921
_d11883921